My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 155

    1.

    Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates.

    Adams AB, Shirasugi N, Durham MM, Strobert E, Anderson D, Rees P, Cowan S, Xu H, Blinder Y, Cheung M, Hollenbaugh D, Kenyon NS, Pearson TC, Larsen CP.

    Diabetes. 2002 Feb;51(2):265-70.PMID: 11812731 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Anti-CD40 therapy extends renal allograft survival in rhesus macaques.

    Pearson TC, Trambley J, Odom K, Anderson DC, Cowan S, Bray R, Lin A, Hollenbaugh D, Aruffo A, Siadak AW, Strobert E, Hennigar R, Larsen CP.

    Transplantation. 2002 Oct 15;74(7):933-40.PMID: 12394833 [PubMed - indexed for MEDLINE]Related articles

    3.

    New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.

    Sho M, Sandner SE, Najafian N, Salama AD, Dong V, Yamada A, Kishimoto K, Harada H, Schmitt I, Sayegh MH.

    Ann Surg. 2002 Nov;236(5):667-75.PMID: 12409674 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.

    Guo Z, Wu T, Kirchhof N, Mital D, Williams JW, Azuma M, Sutherland DE, Hering BJ.

    Transplantation. 2001 Jun 15;71(11):1656-65.PMID: 11435979 [PubMed - indexed for MEDLINE]Related articles

    5.

    Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival.

    Adams AB, Shirasugi N, Jones TR, Durham MM, Strobert EA, Cowan S, Rees P, Hendrix R, Price K, Kenyon NS, Hagerty D, Townsend R, Hollenbaugh D, Pearson TC, Larsen CP.

    J Immunol. 2005 Jan 1;174(1):542-50.PMID: 15611281 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.

    Fan K, Wang H, Wei H, Zhou Q, Kou G, Hou S, Qian W, Dai J, Li B, Zhang Y, Zhu T, Guo Y.

    Transplantation. 2007 Sep 27;84(6):746-54.PMID: 17893608 [PubMed - indexed for MEDLINE]Related articles

    7.

    Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation.

    Dengler TJ, Szabo G, Sido B, Nottmeyer W, Zimmerman R, Vahl CF, Hünig T, Meuer SC.

    Transplantation. 1999 Feb 15;67(3):392-8.PMID: 10030284 [PubMed - indexed for MEDLINE]Related articles

    8.

    An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection.

    Ferrari-Lacraz S, Zheng XX, Kim YS, Li Y, Maslinski W, Li XC, Strom TB.

    J Immunol. 2001 Sep 15;167(6):3478-85.PMID: 11544341 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.

    Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong Y, Gray GS, Hong X, Thomas D, Fechner JH Jr, Knechtle SJ.

    Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8789-94.PMID: 9238056 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.

    Demirci G, Strom TB, Li XC.

    J Immunol. 2003 Oct 1;171(7):3878-85.PMID: 14500690 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs survival in small bowel transplantation.

    Kurlberg G, Haglind E, Schön K, Törnqvist H, Lycke N.

    Scand J Immunol. 2000 Mar;51(3):224-30.PMID: 10736090 [PubMed - indexed for MEDLINE]Related articles

    12.

    Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways.

    Safley SA, Kapp LM, Tucker-Burden C, Hering B, Kapp JA, Weber CJ.

    Transplantation. 2005 Feb 27;79(4):409-18.PMID: 15729166 [PubMed - indexed for MEDLINE]Related articles

    13.

    CTLA4-Ig: a novel immunosuppressive agent.

    Najafian N, Sayegh MH.

    Expert Opin Investig Drugs. 2000 Sep;9(9):2147-57. Review.PMID: 11060799 [PubMed - indexed for MEDLINE]Related articles

    14.

    Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival.

    Nanji SA, Hancock WW, Anderson CC, Adams AB, Luo B, Schur CD, Pawlick RL, Wang L, Coyle AJ, Larsen CP, Shapiro AM.

    Am J Transplant. 2004 Apr;4(4):526-36.PMID: 15023144 [PubMed - indexed for MEDLINE]Related articles

    15.

    Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade.

    Bühler L, Deng S, O'Neil J, Kitamura H, Koulmanda M, Baldi A, Rahier J, Alwayn IP, Appel JZ, Awwad M, Sachs DH, Weir G, Squifflet JP, Cooper DK, Morel P.

    Xenotransplantation. 2002 Jan;9(1):3-13.PMID: 12005102 [PubMed - indexed for MEDLINE]Related articles

    16.

    Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.

    Pan H, Lu HM, Hu WM, Tian BL, Liu XB, Zhang ZD, Mai G.

    Transplant Proc. 2007 Dec;39(10):3452-4.PMID: 18089405 [PubMed - indexed for MEDLINE]Related articles

    17.

    Combination therapy with anti-ICOS and cyclosporine enhances cardiac but not islet allograft survival.

    Nanji SA, Hancock WW, Anderson CC, Zhu LF, Kneteman NM, Shapiro AM.

    Transplant Proc. 2003 Nov;35(7):2477-8.PMID: 14611990 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cyclophosphamide, but not CTLA4Ig, prolongs survival of fetal pig islet grafts in anti-T cell monoclonal antibody-treated NOD mice.

    Koulmanda M, Kovarik J, Mandel TE.

    Xenotransplantation. 1998 Aug;5(3):215-21.PMID: 9741460 [PubMed - indexed for MEDLINE]Related articles

    19.

    Co-stimulatory molecules in islet xenotransplantation: CTLA4Ig treatment in CD40 ligand-deficient mice.

    Benda B, Ljunggren HG, Peach R, Sandberg JO, Korsgren O.

    Cell Transplant. 2002;11(7):715-20.PMID: 12518898 [PubMed - indexed for MEDLINE]Related articles

    20.

    Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.

    Molano RD, Pileggi A, Berney T, Poggioli R, Zahr E, Oliver R, Malek TR, Ricordi C, Inverardi L.

    Transplantation. 2003 Jun 15;75(11):1812-9.PMID: 12811239 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity